Viridian Therapeutics Inc (NASDAQ:VRDN)

13.66
Delayed Data
As of Aug 05
 +0.06 / +0.44%
Today’s Change
9.47
Today|||52-Week Range
22.00
-30.91%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Viridian Therapeutics Inc have a median target of 32.00, with a high estimate of 40.00 and a low estimate of 25.00. The median estimate represents a +134.26% increase from the last price of 13.66.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Viridian Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.90
Sales
$270.3K
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.45%
 
 
 
 
 
 
Growthannually 43.20%
 
 
 
 
 
 

Sales

Growthquarterly 25.15%
 
 
 
 
 
 
Growthannually -70.49%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.